Trending Health

In this Trending News Europe episode, Jack, Jen, and Ollie discuss recent newsworthy items from across Europe, including the impact of and deterrents against “no shows” at medical appointments, therole bacteria play in cancer treatment, and inequalities in the rare disease market, along with the steps being taken to ease these issues.

Podcast Tags: healthcare, healthcare news, life sciences, public health, France, medical, bacteria, cancer, immunotherapy, chemotherapy, microbiome, rare disease, Germany, Italy, health disparity

Source Links:

• Dutch hospitals use AI to solve no-show patient problems that cost them millions
• Cancellations of NHS care are having serious impacts on two-thirds of patients
• Would charging patients for missed appointments help fund the NHS?
• GP \’no shows\’ cost Norfolk NHS more than 1m in a one month
• France planning €5 no-show fees in a bid to improve community healthcare
• France divided over ‘no-show tax’ for patients failing medical appointments
• Researchers compile detailed catalog of bacteria living in cancer metastases
• Boehringer builds out cancer capabilities with $500M deal for bacteria-focused Swiss biotech
• The key to young onset bowel cancer may be gut bacteria
• The mystery of microbes that live inside tumours
• Diversity of Bacteria in Cancer Metastases
• It’s the Little Things: A Role for Bacteria in Cancer Treatment
• The UK is missing out on EU collaboration to improve treatment for rare diseases
• Overcoming the burden of rare diseases in Europe
• Stronger together in the fight against rare diseases
• Is Europe on track to be the leader in rare diseases?
• Right here, right now European public health policies must start giving people living with rare diseases a fair chance
• New rare diseases action plan on horizon, Europe at turning point
• Europe needs new 360 rare diseases strategy

Panel – Jack Young, Jen Burke, Ollie May

Research & Production – Karan Pandya

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In recent years, we’ve seen an increasing number of Life Sciences companies publicly declare commitments to sustainability efforts as a result of increased pressure from governments, customers, and research. Trending Health UK’s Ollie May sits down with two members of Vynamic’s Sustainability Council, Rosanna Vellacott and Matt O’Dell, to discuss why pharmaceutical organizations should be paying attention to sustainability goals, some innovative practices underway, and what leaders should be considering as they embed more sustainable practices into their organizations.

Podcast Tags: healthcare, life sciences, sustainability, healthcare news, climate change, climate crisis, emissions, net zero, supply chain

Source Links:

• Striving for sustainable drug discovery using Green Chemistry
• Accelerating the transition to net zero in life sciences
• Process Digital Twin for Pharma
• Sanofi harnesses Dassault\’s digital twin tech to optimize production at future vaccine plants
• Strategies for Sustainability in the Global Pharmaceutical Supply Chain
• Bayer: Improving Sustainability Practices in the Supply Chain
• Bayer: Commitments in Action Creating a Sustainable Product Supply
• Making biopharma’s supply chains more environmentally sustainable
• The pharma companies working towards supply chain sustainability
• Carbon footprint of the global pharmaceutical industry and relative impact of its major players
• The Greenhouse Gas Protocol: Technical Report
• Understanding pharma’s challenges and opportunities in relation to the climate crisis
• Pharmaceutical Company Targets and Strategies to Address Climate Change: Content Analysis of Public Reports from 20 Pharmaceutical Companies
• Pharma’s path to Net Zero: Targeting Scope 3 emissions

Panel – Oliver May, Rosanna Vellacott, Matt O’Dell

Research & Production – Adrea Cope, Everly Petruzzelli, Oliver May

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this Trending News US episode, Jen, Mindy, and Ryan discuss recent newsworthy items, including the introduction of rebate credits by CVS to account for more biosimilars entering the market, as well as a recent ruling by a federal appeals court that drugmakers cannot restrict 340B program offerings from community and specialty pharmacies. Finally, we discuss a groundbreaking procedure in which a kidney from a CRISPR gene edited pig was transplanted into a human.

Podcast Tags: healthcare, healthcare news, CVS health, PBMs, biosimilars, 340B, pharmacies, hospitals, providers, xenotransplantation, CRISPR, gene editing

Source Links:

• As Humira biosimilars take over the market, CVS has created a new ploy; the drug “rebate credit”
• Federal appeals court sides with 340B contract pharmacies
• American Hospital Association 340B Factsheet
• Gene edited pig kidney transplanted into a living patient for the first time
• Kidney Disease Statistics for the United States

Panel – Jen Burke, Mindy McGrath, Ryan Hummel

Research & Production – Anna Briccetti, Jen Burke

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

One of the core tenets of the omnichannel philosophy is continuous learning and refinement – bringing together experience and data to evolve the marketing and model.Jen is joined by Vynamic’s Customer Experience Transformation Lead Mike Zapiec and Omnichannel Offering Lead Josh Padams to discuss what we’ve learned partnering with clients to build their omnichannel capabilities and what Life Sciences organizations can do to take their customer engagement to the next level.

For more information on Vynamic’s work in Customer Experience Transformation, check out our service page:https://vynamic.com/what-we-do/services/customer-experience-transformation-cxt/

Podcast Tags: omnichannel, customer engagement, customer experience, marketing, healthcare, life sciences

Panel – Mike Zapiec, Josh Padams, Jen Burke

Research & Production – Danielle Lewis, Hannah Yee, Aisling McAtamney, Jen Burke

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jack, Ollie, and Jen discuss a substantial investment package in the UK’s Life Sciences and manufacturing sectors, the role of an AI chatbot in bridging Europe\’s mental health care gap, and how Spain is reshaping pharmaceutical supply chains in Europe.

Podcast Tags: healthcare, Europe, healthcare news, manufacturing, research, AI, chatbots, mental health, patient care, Spain, supply chain

Source Links:

• UK lacks plans to make pandemic vaccines quickly, MPs hear
• Spring Budget puts UK on fast-track to becoming science and technology superpower
• UK Spring Budget allocates funds to life sciences manufacturing
• £360 million to boost British manufacturing and R&D
• ABPI response to the Budget
• UK Chancellor trumpets £650m AstraZeneca investment
• Meet the AI chatbot therapists filling the gaps in Europe’s mental health care shortfall
• Mental health services facing ‘vicious cycle’ workforce issue
• A chatbot helped more people access mental-health services
• Closing the accessibility gap to mentalhealth treatment with a personalized self-referral chatbot
• A child in Poland has to wait 238 days to see a psychiatrist, activist says
• From ‘crisis’ to ‘pandemic’: mental health in Europe
• Europe\’s mental health crisis: Which country uses the most antidepressants?
• Belgium leads the charge on the EU’s medicines reshoring plans
• EU capitals propose Chips Act for medicines
• Onshoring and global health – has the pandemic sent globalisation into reverse?
• France\’s Emmanuel Macron seeks to relocate domestic production of key drugs to avoid shortages
• Barcelona identified as Europe’s second-best hub for biotech investment
• Moderna opens international centre for analytical excellence in Madrid
• Spain showing great pharma potential as Barcelona named Europe’s No.2 hub for biotech investment
• Spain Has All the Right Elements To Become a Fast-Growing Life Science Hub
• Spain’s plan to become Europe’s pharmaceutical epicentre

Panel – Jack Young, Jen Burke, Ollie May

Research & Production – Jack Young, Karan Pandya, Ollie May

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at1-888-VYNAMIC.

The obesity drug market has grown dramatically in the last few years, especially with the help of social media and influencers. The immense popularity of anti-obesity medications has transformed a health industry development into a cultural phenomenon. While this market has so much opportunity, it also faces supply issues and coverage gaps. Mindy and Jen are joined by Vynamic’s Head of Life Sciences, Karen Baldry, and Head of Health Plans, Saurabh Raman, to talk about the growth and challenges obesity medications present for the health industry.

Podcast Tags: healthcare, obesity, weight loss, diabetes, health services, health plans, life sciences

Source Links:

• What Is Ozempic and Why Is It Getting So Much Attention?
• We Know Where New Weight Loss Drugs Came From, but Not Why They Work
• What the Scientists Who Pioneered Weight-Loss Drugs Want You to Know
• Supply Updates about Wegovy
• The increase in appetite for obesity drugs
• Demand for GLP-1 drugs is growing. Here\’s why payers are hesitant to cover them for weight loss
• More than 4,000 ads for Ozempic-style drugs found running on Instagram and Facebook
• Wegovy heart health data is promising — but insurers face long road, high cost to cover obesity drugs
• Medicare is barred from paying for weight-loss drugs like Wegovy. Lawmakers just took the first step to change that
• Cost isn’t the only reason Medicare doesn’t cover Wegovy
• New marketing push by Ozempic and others sparks body-positive backlash
• What You Need to Know About Compounded Versions of Popular Weight Loss Drugs
• Novo antes up $16.5B to poach CDMO giant Catalent amid Wegovy surge
• Wegovy, other GLP-1s could lower heart disease: Study
• Novo kidney trial finds Ozempic cuts cardiac deaths in diabetics
• How Ozempic and Weight Loss Drugs Are Reshaping Denmark’s Economy
• Novo Nordisk\’s Wegovy bonanza looms large in Denmark
• Big pharma’s blockbuster obesity drug battle is just getting started, and it’s headed for $100 billion
• Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect
• Ozempic vs Wegovy
• Obesity drug boom pushes Novo Nordisk shares to record high
• Popular use of obesity drugs like Ozempic could change consumer habits

Panel – Jen Burke, Mindy McGrath, Karen Baldry, Saurabh Raman

Research & Production – Adrea Cope, Everly Petruzzelli

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Since it was signed into law in 2022, the health industry has been abuzz about the longer-term impact of the Inflation Reduction Act. In this episode, Jen & Mindy sit down to discuss recent headlines and developments around this landmark legislation and what Life Sciences companies should expect over the course of the next year.

For more perspective on the Inflation Reduction Act\’s impact on Life Sciences companies, check out Mindy’s article in Pharmaphorum, "Seizing the moment: The life sciences industry at the threshold of change”.

Podcast Tags: healthcare, healthcare news, life sciences, health policy, inflation reduction act, drug prices, pharmaceutical

Panel – Jen Burke, Mindy McGrath

Research & Production – Jen Burke, Mindy McGrath

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the ruling by Alabama’s Supreme Court that frozen embryos can be legally regarded as “extrauterine children” under state law, and the impact this decision has had on in vitro fertilization (IVF) procedures. They also cover the release of additional guidance from CMS on the Medicare Prescription Payment Plan and a new report from Reuters that revealed the dramatic increase in new drug prices throughout 2023.

Podcast Tags: healthcare, healthcare news, IVF, embryos, supreme court, reproductive health, life sciences, health policy, inflation reduction act, CMS, medicare, medicaid, drug prices, pharmaceutical

Source Links:

• The science of IVF: What to know about Alabama\’s \’extrauterine children\’ ruling
• Rare Diseases at FDA
• Prices for new US drugs rose 35% in 2023, more than the previous year.

Panel – Jen Burke, Mindy McGrath, Ryan Hummel

Research & Production – Anna Briccetti, Jen Burke

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jack, Ollie, and Jen discuss some recent European-based newsworthy items, covering a prominent oncology society\’s push for tumor classification reform that could have profound impacts on cancer survival rates, the critical need for measles vaccination, and Sweden\’s pioneering use of drones in cardiac arrest intervention.

Podcast Tags: healthcare, healthcare news, life sciences, precision oncology, cancer, molecular testing, infectious diseases, vaccination, NHS sustainability, innovation, Sweden

Source Links:

• We’re naming cancers all wrong, oncology leader says
• Forget lung, breast or prostate cancer: why tumour naming needs to change
• Redefining Cancer Classification: A Shift from Organ-based to Molecular-based Approach
• A 30-fold rise of measles cases in 2023 in the WHO European Region warrants urgent action
• Measles in Europe: WHO calls for ‘urgent’ vaccinations as cases surge
• Europe Needs to Get on Top of Its Measles Outbreak
• Europe faces resurgence of measles due to low vaccination coverage
• Europe\’s first transport of blood bags by drone takes place in Belgium
• NHS to pioneer drone deliveries in bid to improve service
• Drone chemotherapy becomes an NHS net zero cancer strategy
• Sweden uses drones to fight cardiac arrest
• Healthcare From Above: Challenges And Opportunities Of Medical Drones
• Flight Trials for Scots Medicine-carrying Drones Conducted
• Government to invest £30 million in innovative technology for NHS
• Department of Health and Social Care: Medical Technology Strategy
• Drones to deliver NHS medication to care homes and GP surgeries in major roll-out
• NHS to begin delivering critical medical supplies by drone

Panel – Jack Young, Jen Burke, Ollie May

Research & Production – Jack Young, Karan Pandya, Ollie May

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at1-888-VYNAMIC.

Over the last few years, the MedTech market has been navigating an unpredictable environment due to macro-economic factors and pandemic-driven activity. As we start off 2024, there’s a prevailing feeling that this market is finally starting to stabilize. In this episode, Jen is joined by Vynamic’s Anila Patel and Head of Health Technology Sector, Mary Virzi, to chat about what MedTech moves we’ve seen so far and what we can expect as 2024 kicks into gear.

Podcast Tags: healthcare, medtech, product launch, medical device, health tech, healthcare technology

Source Links:

• The biggest stories from the 2024 J.P. Morgan Healthcare Conference
• 5 medtech trends to watch in 2024
• MEDTECH AND DIAGNOSTICS MARKET: 2023 TRENDS AND 2024 OUTLOOK
• Medtronic aims to leverage medical device data for AI-enabled care
• 4 heart device trends shaping the medtech sector in 2024
• J&J\’s Biosense Webster puts forward pulsed field ablation data showing no afib after one year
• Boston Scientific nets Farapulse approval, pushes back US TAVR launch
• J&J\’s Biosense Webster puts forward pulsed field ablation data showing no afib after one year
• Medtronic snags first pulsed field ablation approval in US
• Spotlight – J&J takes on Medtronic and Boston in pulsed field ablation
• Increasing diabetes awareness boosts the diabetes care devices market

Panel – Mary Virzi, Anila Patel, Jen Burke

Research & Production – Adrea Cope, Everly Petruzzelli

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.